Dr Stephen Matthew Pirrone, DO - Medicare Diagnostic Radiology in Louisville, KY

Dr Stephen Matthew Pirrone, DO is a medicare enrolled "Radiology - Vascular & Interventional Radiology" physician in Louisville, Kentucky. He went to Rutgers New Jersey Medical School and graduated in 2003 and has 21 years of diverse experience with area of expertise as Diagnostic Radiology. He is a member of the group practice Lourdes Imaging Associates Pa and his current practice location is 3507 Sasse Way, Louisville, Kentucky. You can reach out to his office (for appointments etc.) via phone at (856) 986-3263.

Dr Stephen Matthew Pirrone is licensed to practice in Kentucky (license number 01386) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1063613107.

Contact Information

Dr Stephen Matthew Pirrone, DO
3507 Sasse Way,
Louisville, KY 40245-8516
(856) 986-3263
Not Available



Physician's Profile

Full NameDr Stephen Matthew Pirrone
GenderMale
SpecialityDiagnostic Radiology
Experience21 Years
Location3507 Sasse Way, Louisville, Kentucky
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Stephen Matthew Pirrone attended and graduated from Rutgers New Jersey Medical School in 2003
  NPI Data:
  • NPI Number: 1063613107
  • Provider Enumeration Date: 05/29/2007
  • Last Update Date: 06/26/2012
  Medicare PECOS Information:
  • PECOS PAC ID: 3971643354
  • Enrollment ID: I20140515002049

Medical Identifiers

Medical identifiers for Dr Stephen Matthew Pirrone such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1063613107NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
2085R0204XRadiology - Vascular & Interventional Radiology 01386 (Kentucky)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Virtua Willingboro HospitalWillingboro, NJHospital
Virtua Our Lady Of Lourdes HospitalCamden, NJHospital
Virtua West Jersey HospitalsVoorhees, NJHospital
Virtua Memorial Hospital Of Burlington CountyMount holly, NJHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Lourdes Imaging Associates Pa226448023514

News Archive

Inofile receives nearly 80 certifications at IHE North American Connectathon

Inofile announced today that it received nearly 80 certifications at the Integrating Healthcare Enterprise (IHE) North American Connectathon, a national health information system and technology testing event for the healthcare industry.

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore found that deactivating a specific protein - interleukin 11 - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver in patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis .

Elective single embryo transfer for Canadian women under 35 most efficacious and cost-effective option

Many Canadian couples battling infertility turn to in vitro fertilization (IVF) to have a child. In Canada, IVF is not publicly funded, making the decision on the number of embryos to be transferred more complicated than in many European countries which link funding to elective single embryo transfer (eSET).

Cerebral protection device reduces brain lesions after TAVI in patients with severe aortic stenosis

Among patients with severe aortic stenosis (narrowing of the aortic valve) undergoing transcatheter aortic valve implantation, the use of a cerebral protection device (a filter that captures debris [tissue and plaque] dislodged during the procedure) reduced the number and volume of brain lesions, according to a study appearing in the August 9 issue of JAMA.

Nabi Biopharmaceuticals commences second Phase III study of NicVAX for treating nicotine addiction

Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.

Read more Medical News

› Verified 6 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Stephen Matthew Pirrone allows following entities to bill medicare on his behalf.
Entity NameLourdes Imaging Associates Pa
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1952330599
PECOS PAC ID: 2264480235
Enrollment ID: O20050107000262

News Archive

Inofile receives nearly 80 certifications at IHE North American Connectathon

Inofile announced today that it received nearly 80 certifications at the Integrating Healthcare Enterprise (IHE) North American Connectathon, a national health information system and technology testing event for the healthcare industry.

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore found that deactivating a specific protein - interleukin 11 - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver in patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis .

Elective single embryo transfer for Canadian women under 35 most efficacious and cost-effective option

Many Canadian couples battling infertility turn to in vitro fertilization (IVF) to have a child. In Canada, IVF is not publicly funded, making the decision on the number of embryos to be transferred more complicated than in many European countries which link funding to elective single embryo transfer (eSET).

Cerebral protection device reduces brain lesions after TAVI in patients with severe aortic stenosis

Among patients with severe aortic stenosis (narrowing of the aortic valve) undergoing transcatheter aortic valve implantation, the use of a cerebral protection device (a filter that captures debris [tissue and plaque] dislodged during the procedure) reduced the number and volume of brain lesions, according to a study appearing in the August 9 issue of JAMA.

Nabi Biopharmaceuticals commences second Phase III study of NicVAX for treating nicotine addiction

Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.

Read more Medical News

› Verified 6 days ago

Entity NameInspira Health Network Medical Group Pc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1922177856
PECOS PAC ID: 4880797570
Enrollment ID: O20070319000280

News Archive

Inofile receives nearly 80 certifications at IHE North American Connectathon

Inofile announced today that it received nearly 80 certifications at the Integrating Healthcare Enterprise (IHE) North American Connectathon, a national health information system and technology testing event for the healthcare industry.

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore found that deactivating a specific protein - interleukin 11 - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver in patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis .

Elective single embryo transfer for Canadian women under 35 most efficacious and cost-effective option

Many Canadian couples battling infertility turn to in vitro fertilization (IVF) to have a child. In Canada, IVF is not publicly funded, making the decision on the number of embryos to be transferred more complicated than in many European countries which link funding to elective single embryo transfer (eSET).

Cerebral protection device reduces brain lesions after TAVI in patients with severe aortic stenosis

Among patients with severe aortic stenosis (narrowing of the aortic valve) undergoing transcatheter aortic valve implantation, the use of a cerebral protection device (a filter that captures debris [tissue and plaque] dislodged during the procedure) reduced the number and volume of brain lesions, according to a study appearing in the August 9 issue of JAMA.

Nabi Biopharmaceuticals commences second Phase III study of NicVAX for treating nicotine addiction

Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.

Read more Medical News

› Verified 6 days ago

Entity NameSjvi Llc
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1386885226
PECOS PAC ID: 0547318040
Enrollment ID: O20090511000046

News Archive

Inofile receives nearly 80 certifications at IHE North American Connectathon

Inofile announced today that it received nearly 80 certifications at the Integrating Healthcare Enterprise (IHE) North American Connectathon, a national health information system and technology testing event for the healthcare industry.

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore found that deactivating a specific protein - interleukin 11 - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver in patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis .

Elective single embryo transfer for Canadian women under 35 most efficacious and cost-effective option

Many Canadian couples battling infertility turn to in vitro fertilization (IVF) to have a child. In Canada, IVF is not publicly funded, making the decision on the number of embryos to be transferred more complicated than in many European countries which link funding to elective single embryo transfer (eSET).

Cerebral protection device reduces brain lesions after TAVI in patients with severe aortic stenosis

Among patients with severe aortic stenosis (narrowing of the aortic valve) undergoing transcatheter aortic valve implantation, the use of a cerebral protection device (a filter that captures debris [tissue and plaque] dislodged during the procedure) reduced the number and volume of brain lesions, according to a study appearing in the August 9 issue of JAMA.

Nabi Biopharmaceuticals commences second Phase III study of NicVAX for treating nicotine addiction

Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.

Read more Medical News

› Verified 6 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Stephen Matthew Pirrone is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Stephen Matthew Pirrone, DO
3507 Sasse Way,
Louisville, KY 40245-8516

Ph: (856) 986-3263
Dr Stephen Matthew Pirrone, DO
3507 Sasse Way,
Louisville, KY 40245-8516

Ph: (856) 986-3263

News Archive

Inofile receives nearly 80 certifications at IHE North American Connectathon

Inofile announced today that it received nearly 80 certifications at the Integrating Healthcare Enterprise (IHE) North American Connectathon, a national health information system and technology testing event for the healthcare industry.

Deactivating specific protein with drugs reverses inflammation, scarring of liver in NASH patients

A team of researchers led by Duke-NUS Medical School and National Heart Centre Singapore found that deactivating a specific protein - interleukin 11 - with drugs called therapeutic antibodies, reverses inflammation and scarring of the liver in patients suffering from an untreatable type of fatty liver disease called non-alcoholic steatohepatitis .

Elective single embryo transfer for Canadian women under 35 most efficacious and cost-effective option

Many Canadian couples battling infertility turn to in vitro fertilization (IVF) to have a child. In Canada, IVF is not publicly funded, making the decision on the number of embryos to be transferred more complicated than in many European countries which link funding to elective single embryo transfer (eSET).

Cerebral protection device reduces brain lesions after TAVI in patients with severe aortic stenosis

Among patients with severe aortic stenosis (narrowing of the aortic valve) undergoing transcatheter aortic valve implantation, the use of a cerebral protection device (a filter that captures debris [tissue and plaque] dislodged during the procedure) reduced the number and volume of brain lesions, according to a study appearing in the August 9 issue of JAMA.

Nabi Biopharmaceuticals commences second Phase III study of NicVAX for treating nicotine addiction

Nabi Biopharmaceuticals announced that it has initiated the second of two pivotal Phase III clinical trials for NicVAX® (Nicotine Conjugate Vaccine), the company's innovative and proprietary vaccine to treat nicotine addiction and prevent smoking relapse. The FDA has agreed with Nabi on the study design, protocol and end points through a Special Protocol Assessment (SPA). The SPA forms a basic foundation to support approval of a New Drug Application. The Company also received scientific advice from the European Medicines Agency (EMEA) that confirms and supports the trial protocol.

Read more News

› Verified 6 days ago


Radiology Doctors in Louisville, KY

Dr. Sohail Contractor, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 530 S Jackson St, Louisville, KY 40202
Phone: 502-852-5875    
Dr. Mark S Cornett, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 315 E Broadway, Louisville, KY 40202
Phone: 502-629-2500    Fax: 502-629-3165
Dr. Christopher Blair Cornell, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 1 Audubon Plaza Dr # 276, Louisville, KY 40217
Phone: 502-447-8786    Fax: 502-447-8623
Dr. Andrew John Collins, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 530 S Jackson St # C07, Louisville, KY 40202
Phone: 502-852-5875    
Dr. Cynthia H Hart, MD
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 200 Abraham Flexner Way, Louisville, KY 40202
Phone: 502-587-4231    Fax: 502-583-2733
Dr. Shannon Ogden Steed, M.D.
Radiology
Medicare: Accepting Medicare Assignments
Practice Location: 4001 Dutchmans Ln # 276, Louisville, KY 40207
Phone: 502-447-8786    Fax: 502-447-8623
Theodore Lee, MD
Radiology
Medicare: Medicare Enrolled
Practice Location: 200 E Chestnut St, Louisville, KY 40202
Phone: 502-629-7601    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.